Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DLGAP3 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | CIB1 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | TET3 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | DPYSL5 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
mRNA | TMOD2 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
mRNA | PELI2 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | S100A16 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
mRNA | ZNF780B | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | EIF4EBP2 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | ADAMTSL5 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |